Investors Late Over AbbVie's Failed Shire Deal, Court Says
By David Hansen · February 7, 2022, 6:38 PM EST
A pair of hedge funds missed the statute of limitations for claiming pharmaceutical company AbbVie Inc. made fraudulent statements in a proposed $54 billion tax inversion with Irish biotech company Shire,...
To view the full article, register now.
Try a seven day FREE Trial
Already a subscriber? Click here to login